In 526 HBV-seronegative MSM in Taiwan, double-dose vs standard-dose HBV revaccination gave Week 28 seroprotection of 96.7% vs 92.2% (per-protocol), not meeting the superiority threshold. High-level seroprotection at Week 48 (secondary) was higher: 74.8% vs 62.8%.
RCTn = 526
Huang et al. Hepatitis B virus (HBV) revaccination in MSM who were born in the nationwide neonatal HBV vaccination era: A randomized clinical trial